| Hypertension in pregnancy: a comprehensive update. | |
| | |
MedLine Citation:
|
PMID: 20539101 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hypertensive disorders of pregnancies remain a central public health concern throughout the world, and are a major cause of maternal mortality in the developing world. Although treatment options have not significantly changed in recent years, insight on the pathogenesis of preeclampsia/eclampsia has been remarkable. With improved animal models of preeclampsia and large-scale human trials, we have embarked upon a new era where angiogenic biomarkers based on mechanism of disease can be designed to assist in early diagnosis and treatment. There is also a growing recognition of how elusive the diagnosis of eclampsia can be, especially in the postpartum period. Proper treatment of these patients depends heavily on the correct diagnosis, especially by the emergency physician. Finally, large epidemiologic studies have revealed that preeclampsia, once thought to be a self-limited entity, now appears to portend real damage to the cardiovascular and other organ systems in the long term. This review will present the latest update on our understanding of the various hypertensive disorders of pregnancies and their treatment options. |
| | |
Authors:
|
Belinda Jim; Shuchita Sharma; Tewabe Kebede; Anjali Acharya |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiology in review Volume: 18 ISSN: 1538-4683 ISO Abbreviation: Cardiol Rev Publication Date: 2010 Jul-Aug |
Date Detail:
|
Created Date: 2010-06-11 Completed Date: 2010-10-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304686 Medline TA: Cardiol Rev Country: United States |
Other Details:
|
Languages: eng Pagination: 178-89 Citation Subset: IM |
Affiliation:
|
Renal Division, Department of Medicine, Jacobi Medical Center, Bronx, NY 10461, USA. Belinda_bun_jim@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
therapeutic use Biological Markers / metabolism Chronic Disease Delivery, Obstetric / methods Dietary Supplements Female Humans Hypertension / classification, diagnosis*, metabolism, physiopathology, therapy* Hypertension, Pregnancy-Induced / diagnosis, metabolism, physiopathology, therapy Podocytes / metabolism Postpartum Period Pregnancy Pregnancy Complications, Cardiovascular / classification, diagnosis*, metabolism, physiopathology, therapy* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Biological Markers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Resting measures and physiological responses to exercise for the determination of prognosis in patie...
Next Document: Nitrates and nitrites in the treatment of ischemic cardiac disease.